scholarly journals Minimally invasive comprehensive treatment for granulomatous lobular mastitis

2020 ◽  
Author(s):  
Yaohuai Wang ◽  
Junlong Song ◽  
Yi Tu ◽  
Chuang Chen ◽  
Shengrong Sun
Keyword(s):  
Retrospective Study ◽  
Minimally Invasive ◽  
Operative Technique ◽  
Treatment Process ◽  
Comprehensive Treatment ◽  
The Past ◽  
Image Characteristics ◽  
Surgical History ◽  
Hospital Stays

Abstract Objective: To describe a minimally invasive comprehensive treatment for granulomatous lobular mastitis (GLM) and compare its effect with the existing methods, particularly in terms of its recurrence rate and esthetic outcomes. Methods: This retrospective study reviewed 69 GLM patients receiving the minimally invasive comprehensive treatment. Patients’ information, including age, clinical features, image characteristics, histopathological findings, mastitis history, treatment process, operative technique, recurrence, and esthetic effect, was evaluated. Results: All patients were female with a median age of 32 (range 17 - 55) years. Hospital stays ranged from 2 to 34 days, with a median of 6 days. The shortest time for complete rehabilitation was 2 days and the longest time was 365 days, with a median of 30 days. After a median follow-up of 391 days (range 162 - 690), 7 patients (10.14%) relapsed. The average cosmetic score was 2.62 ± 0.57 points and was mainly related to the past treatment, especially the surgical history. Conclusion: Minimally invasive comprehensive treatment is a new method for the treatment of GLM, ensuring a therapeutic effect while maintaining breast beauty.

scholarly journals Minimally invasive comprehensive treatment for granulomatous lobular mastitis

2020 ◽  
Author(s):  
Yaohuai Wang ◽  
Junlong Song ◽  
Yi Tu ◽  
Chuang Chen ◽  
Shengrong Sun
Keyword(s):  
Retrospective Study ◽  
Minimally Invasive ◽  
Operative Technique ◽  
Treatment Process ◽  
Comprehensive Treatment ◽  
The Past ◽  
Image Characteristics ◽  
Surgical History ◽  
Hospital Stays

Abstract Objective: To describe a minimally invasive comprehensive treatment for granulomatous lobular mastitis (GLM) and compare its effect with the existing methods, particularly in terms of its recurrence rate and esthetic outcomes. Methods: This retrospective study reviewed 69 GLM patients receiving the minimally invasive comprehensive treatment. Patients’ information, including age, clinical features, image characteristics, histopathological findings, mastitis history, treatment process, operative technique, recurrence, and esthetic effect, was evaluated. Results: All patients were female with a median age of 32 (range 17 - 55) years. Hospital stays ranged from 2 to 34 days, with a median of 6 days. The shortest time for complete rehabilitation was 2 days and the longest time was 365 days, with a median of 30 days. After a median follow-up of 391 days (range 162 - 690), 7 patients (10.14%) relapsed. The average cosmetic score was 2.62 ± 0.57 points and was mainly related to the past treatment, especially the surgical history. Conclusion: Minimally invasive comprehensive treatment is a new method for the treatment of GLM, ensuring a therapeutic effect while maintaining breast beauty.

scholarly journals Minimally invasive comprehensive treatment for granulomatous lobular mastitis

2019 ◽  
Author(s):  
Yaohuai Wang ◽  
Junlong Song ◽  
Yi Tu ◽  
Chuang Chen ◽  
Shengrong Sun
Keyword(s):  
Retrospective Study ◽  
Minimally Invasive ◽  
Operative Technique ◽  
Treatment Process ◽  
Comprehensive Treatment ◽  
The Past ◽  
Image Characteristics ◽  
Surgical History ◽  
Hospital Stays

Abstract Objective: To describe a minimally invasive comprehensive treatment for granulomatous lobular mastitis (GLM) and compare its effect with the existing methods, particularly in terms of its recurrence rate and esthetic outcomes. Methods: This retrospective study reviewed 69 GLM patients receiving the minimally invasive comprehensive treatment. Patients’ information, including age, clinical features, image characteristics, histopathological findings, mastitis history, treatment process, operative technique, recurrence, and esthetic effect, was evaluated. Results: All patients were female with a median age of 32 (range 17 - 55) years. Hospital stays ranged from 2 to 34 days, with a median of 6 days. The shortest time for complete rehabilitation was 2 days and the longest time was 365 days, with a median of 30 days. After a median follow-up of 391 days (range 162 - 690), 7 patients (10.14%) relapsed. The average cosmetic score was 2.62 ± 0.57 points and was mainly related to the past treatment, especially the surgical history. Conclusion: Minimally invasive comprehensive treatment is a new method for the treatment of GLM, ensuring a therapeutic effect while maintaining the breast beauty.

scholarly journals Surgical Techniques and the Choice of Operative Approach for Cranioorbital Lesions

2019 ◽  
Vol 81 (06) ◽  
pp. 686-693
Author(s):  
Haiyong He ◽  
Meiqin Cai ◽  
Manting Li ◽  
Lei Wei ◽  
Lun Luo ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Optic Nerve ◽  
Minimally Invasive ◽  
Surgical Techniques ◽  
Surgical Approaches ◽  
Modified Rankin Scale ◽  
Pterional Approach ◽  
Total Resection ◽  
Significant Difference

Abstract Objectives Cranioorbital lesions present a great challenge for neurosurgeons and ophthalmologists. There is no consensus on the choice of surgical approach. The aims of this study were to investigate 49 cases of cranioorbital lesions and evaluate surgical approaches and outcomes. Patients and Methods A retrospective study was done on 49 patients (51 operations) from 2009 to 2018. Information about the lesion was used to decide whether the supraorbital eyebrow approach (SEA) or pterional approach (PA) was performed. Results Twenty-eight patients had surgical resection using SEA, 21 patients received PA, each group included one case of recurrence, who underwent reoperation via the same approach. SEA provided better cosmetic satisfaction, and a shorter incision than PA (p < 0.05). There was no significant difference in total resection rates, visual outcomes, recovery of ptosis, and other new surgical-related complications between SEA group and PA group (p > 0.05). Forty-nine cases of proptosis (94.1%, 49/51) were improved. Thirty-three patients (33/37, 89.2%) who underwent follow-up for longer than 12 weeks had a modified Rankin Scale (mRS) score ≤ 3. Conclusion Surgery is the preferred treatment for cranioorbital lesions, but total resection is difficult. SEA may be a more minimally invasive option for some more limited lesions superior to optic nerve. PA may be more reasonable for the lesion with obvious hyperostosis and more extensive lesions.

scholarly journals Revision Tympanomastoid Surgery

2002 ◽  
Vol 81 (10) ◽  
pp. 718-729 ◽  
Author(s):  
Cliff A. Megerian ◽  
Mathew J. Cosenza ◽  
Suzanna E. Meyer
Keyword(s):  
Retrospective Study ◽  
Bone Conduction ◽  
Chronic Otitis Media ◽  
Success Rates ◽  
Cell Disease ◽  
Previous Surgery ◽  
The Past ◽  
Mastoid Surgery ◽  
Causes Of Failure

We conducted a retrospective study of 50 ears in 48 patients in whom we performed revision tympanomastoid surgery for chronic otitis media. We found that the most common probable causes for the failure of previous surgery were incomplete lowering of the facial ridge (94% of cases), persistent sinodural-angle air-cell disease (92%), persistent tegmental air-cell disease (88%), recurrent or persistent cholesteatoma (66%), persistent mastoid-tip air-cell disease (62%), a small meatus (60%), and persistent hypotympanic air-cell disease (56%). After a mean postoperative follow-up of 26 months, we found no appreciable difference in success rates between patients who had undergone only one previous surgery (93%) and those who had undergone more than one previous surgery (95%) prior to referral to our center. Follow-up hearing data revealed a statistically significant improvement in air and bone conduction and a nonsignificant reduction in the air-bone gap. We conclude that revision mastoid surgery following multiple earlier surgical failures does not carry an appreciably higher risk of failure than does initial revision surgery. Moreover, there appears to have been no change in the causes of failure following mastoid surgery over the past 3 decades.

scholarly journals Minimally invasive chevron/akin osteotomy: radiographic outcomes

2021 ◽  
Vol 15 (2) ◽  
pp. 110-114
Author(s):  
Kepler Alencar Mendes de Carvalho ◽  
Fernando Garnica Torrico ◽  
David Satiro Borges Pereira de Oliveira ◽  
André Donato Baptista
Keyword(s):  
Retrospective Study ◽  
Minimally Invasive ◽  
Hallux Valgus ◽  
Level Of Evidence ◽  
Radiographic Outcomes ◽  
Statistical Relevance ◽  
Akin Osteotomy ◽  
The Mean

Objective: To evaluate radiographic outcomes in patients undergoing minimally invasive Chevron/Akin osteotomy (MICA) for hallux valgus correction. Methods: We have treated 31 patients (40 feet). Preoperative and postoperative hallux metatarsophalangeal angles (hallux valgus angles, HVA), intermetatarsal angles (IMA) between the first and second metatarsals, and distal metatarsal articular angles (DMAA) were followed up for 12 months. Results: The mean age of the patients was 53.2 years. Mean preoperative HVA, IMA, and DMAA values were 28.85°, 15.38°, and 14.35°, respectively. The mean postoperative angles measured after 1 year were 10.60°, 7.95°, and 7.48°. Improvements in HVA, IMA, and DMAA values showed statistical relevance. There were no losses in angular parameters during follow-up. Conclusion: The radiographic outcomes in patients undergoing MICA osteotomy for hallux valgus correction followed up for 12 months showed significant improvements and no recurrence of the deformity. Our results suggest that this technique is effective for correcting hallux valgus. Level of Evidence III; Therapeutic Studies; Comparative Retrospective Study.

scholarly journals Open Surgical Excision Versus Endoscopic Radiofrequency Ablation for Piriform Fossa Fistula

2020 ◽  
pp. 014556131989894
Author(s):  
Shilei Pu ◽  
Wanpeng Li ◽  
Hongming Xu ◽  
Liming Zhao ◽  
Xiaojun Liu ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Radiofrequency Ablation ◽  
Minimally Invasive ◽  
Surgical Excision ◽  
Neck Surgery ◽  
Curative Effect ◽  
Advantages And Disadvantages ◽  
Endoscopic Radiofrequency Ablation ◽  
The Mean

Objectives: The purpose of this study is to explore the curative effect of open surgical excision and endoscopic radiofrequency ablation (RA) in the treatment of piriform fossa fistula (PSF). Methods: Retrospective study of 80 cases of PSF in the Department of Otolaryngology-Head and Neck Surgery, Shanghai Children’s Hospital, from June 2009 to June 2017. Results: In this series, there were 43 males and 37 females, and the mean age was 5.2 years (17 days to 12 years). Surgical excision was performed for 62 patients. Radiofrequency ablation was performed for 18 patients. Six cases of postoperative temporary hoarseness occurred, and the hoarseness rates were not significantly different between the excision and RA groups (6.4% vs 11.1%, respectively, P = .88). Two cases of temporary neck abscess occurred in the RA group. After the mean follow-up period of 3.1 years (1-8 years), no recurrence was found between the excision and RA groups. Conclusions: The curative effect of excision and RA for PSF is not significantly different; each of the 2 methods has its advantages and disadvantages. However, RA for PSF has the merit of being minimally invasive, easy to operate, and safe; this procedure seems to be more suitable in the clinic.

Clinical and Radiological Outcomes of Subtalar Arthroereisis for Management of Planovalgus Foot in Children With Cerebral Palsy: 3-Year Follow-up

2020 ◽  
pp. 193864002098091
Author(s):  
Hasan Magdi Elbarbary ◽  
Amr Said Arafa ◽  
Abo Bakr Zein Said ◽  
Mohamed Hegazy ◽  
Mina Waheeb Reiad ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Minimally Invasive ◽  
Prospective Study ◽  
Good Alternative ◽  
Therapeutic Level ◽  
The Past ◽  
Children With Cerebral Palsy ◽  
Subtalar Arthroereisis ◽  
A Prospective Study

Background Planovalgus deformity of the foot is common among cerebral palsy (CP) patients. It is an upcoming topic with debate and controversy that require further studies. Many clinical studies involving arthroereisis have shown acceptable results in short- and mid-term follow-up. The aim of this work was to evaluate the outcome of arthroereisis using a conventional screw placed percutaneously across the talocalcaneal articulation for the treatment of moderate planovalgus deformity in children with CP. Methods Between 2015 and 2018, a prospective study was conducted including 23 CP patients with bilateral flexible planovalgus deformity with follow-up period ranging from 24 to 40 months (mean of 36.7 months). The radiological and clinical outcomes were assessed. The patient/parent outcome was evaluated using the Oxford Ankle Foot Questionnaire for Children (OxAFQ-C). Results The results showed statistically significant improvement in both radiological and clinical data as well as patient’s symptoms and parent’s satisfaction. Conclusion Results obtained from literature from the past decades after arthroereisis for the correction of moderate planovalgus deformity in CP patients are promising. The few studies reported on that procedure shared the same harmony with our study giving a chance to be a good alternative to joint destructive procedures. Our technique is simple, effective, economical, and minimally invasive if used in selected pediatric CP patients. Levels of Evidence Therapeutic, Level IV

Nasal Hydropulsion: A Novel Tumor Biopsy Technique

2011 ◽  
Vol 47 (5) ◽  
pp. 312-316 ◽  
Author(s):  
Elizabeth A. Ashbaugh ◽  
Brendan C. McKiernan ◽  
Carrie J. Miller ◽  
Barbara Powers
Keyword(s):  
High Pressure ◽  
Retrospective Study ◽  
Minimally Invasive ◽  
Small Animal ◽  
Tumor Biopsy ◽  
Therapeutic Technique ◽  
Biopsy Technique ◽  
The Past ◽  
Nasal Tumors ◽  
Nasal Biopsy

Intranasal tumors of dogs and cats pose a diagnostic and therapeutic challenge for small animal practitioners. Multiple nasal biopsy techniques have been described in the past. This report describes a simplified flushing technique to biopsy and debulk nasal tumors, which often also results in immediate clinical relief for the patient. Based on the results of this retrospective study, the authors recommend high-pressure saline hydropulsion as a minimally invasive diagnostic, and potentially therapeutic, technique for nasal tumors in dogs and cats.

scholarly journals A Retrospective Evaluation of the Clinical Success of Transforaminal Endoscopic Discectomy with Foraminotomy in Geriatric Patients

2013 ◽  
Vol 3;16 (3;5) ◽  
pp. 225-229
Author(s):  
Albert E. Telfeian
Keyword(s):  
Retrospective Study ◽  
Minimally Invasive ◽  
General Anesthesia ◽  
Elderly Population ◽  
Geriatric Patients ◽  
The Elderly ◽  
The United States ◽  
Vas Score ◽  
Endoscopic Discectomy

Background: The elderly population is growing in the United States. As the oldest old are projected to be the fastest growing part of the elderly population, we must consider how to best treat their degenerative spine conditions when non-operative treatment fails. Objectives: Transforaminal endoscopic discectomy and foraminotomy is an ultra-minimally invasive outpatient surgical option that does not require general anesthesia and is available to geriatric. The purpose of this study was to assess the benefit of transforaminal endoscopic discectomy and foraminotomy in geriatric patients with single level and multi-level lumbar disc herniations and lumbar radiculopathy. Study Design: Retrospective study Setting: Outpatient surgery center. Methods: After Institutional Review Board Approval, charts from 50 consecutive patients aged 75 and older with complaints of lower back and radicular pain who underwent one or more endoscopic procedures between 2007 and 2011 were reviewed. Results: The average pain relief 6 months postoperatively was reported to be 71.8%, good results as defined by MacNab. The average pre-operative VAS score was 9.04, indicated in our questionnaire as severe and constant pain. The average 6 month post-operative VAS score was 2.63, indicated in our questionnaire as mild and intermittent pain. Limitations: This is a retrospective study and only offers 6 month follow-up data for geriatric patients undergoing endoscopic spine surgery. Conclusions: Endoscopic discectomy is a safe and effective alternative to open back surgery. The 6-month follow-up data presented here appears to indicate that an ultra-minimally invasive approach to the geriatric spine that has a low complication rate, avoids general anesthesia, and is outpatient might be worth studying in a prospective, longer term way. IRB approval: Meridian Health: IRB Study # 201206071J Key words: Endoscopic discectomy, minimally invasive, transforaminal, geriatric

The Dream of a Cure in Multiple Myeloma: A 15-Year Single Center Retrospective Study

Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 5503-5503
Author(s):  
Stefano Pulini ◽  
Annalisa Natale ◽  
Anna Maria Morelli ◽  
Antonio Spadano ◽  
Stefano Angelini ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Retrospective Study ◽  
Partial Response ◽  
Induction Therapy ◽  
Progressive Disease ◽  
Diagnostic Tools ◽  
Cell Transplant ◽  
The Past ◽  
Line Therapy

Abstract Multiple Myeloma (MM) is still considered an incurable disease despite a substantial global outcome improvement observed during the past decade. Despite better understanding of biological pathways, availability of sophisticated diagnostic tools and increasing number of therapeutic options almost all patients experience disease relapse. The aim of our retrospective study was to analyze global outcome in newly diagnosed MM patients eligible for high dose chemotherapy and autologous stem cell transplant (ASCT) treated in our Institution in the last 15 years. We evaluated 177 MM patients transplanted in our Institution from November 1999 to February 2015. Median age at start therapy was 58 years (range 36-71) and median follow up time (from start therapy to last follow up) was 52 months (range 7-185). Patients received different induction therapies before transplant reflecting the availability of new drugs and consequently more therapeutic choices. 65 patients received conventional chemotherapy-based induction (VAD 27, 15%, Total Therapy 2-like 37, 22%, EDAP 1 patient); 15 patients thalidomide-based (TD, 8%); 88 patients bortezomib-based (VTD 74, 43%; VCD 8, 5%; PAD 3, 1%; VD 3, 1%) and 9 patients lenalidomide-based (RD, 5%). After induction regimen 23 patients (13%) received additional therapy before transplant: 14 for Progressive Disease (PD), 9 were considered in suboptimal/unsatisfactory response (5 in Partial Response, PR and 4 in Stable Disease, SD). 71 patients received a single ASCT, 106 patients double ASCT; 11 tandem autologous and allogeneic SCT. All patients had a PR/VGPR/CR after ASCT. Treatment related mortality was 1% (3 patients: 2 of them after Allogenic ASCT, 1 for acute Graft versus Host Disease, 1 for Veno Occlusive Disease). After first line therapy 7 patients died: 3 for progressive disease, 4 for other causes (2 myocardial infarction, 1 intestinal ischemia and 1 breast cancer). 90 patients (51%) experienced MM relapse (median time from ASCT 24 months) and were treated according to different chemotherapy schedules. At last follow-up 115 patients were alive (65%), 61 of them in Complete Response, 31 in Very Good Partial Response, 8 in Partial Response, 4 in SD, 11 in PD. Median global overall survival (OS) was 109 months, median global Progression Free Survival1 (PFS1) 51 months and median global PFS2 (time from start therapy to second disease progression or death from any cause) 80 months. According to different induction therapy (chemotherapy vs bortezomib vs thalidomide vs lenalidomide-based) median OS was 117 months vs not reached (more than 96) vs 68 vs not reached (more than 60); median PFS1 was 47 months vs 60 vs 35 vs not reached (more than 60); median PFS2 was 76 months vs 92 vs 57 vs not reached (more than 60), respectively. As reported in literature the improvement of biological, diagnostic and clinical knowledge and the availability of new therapeutic tools translates in improved outcome in MM patients treated in our Center. The introduction of the proteasome inhibitor bortezomib in the induction therapy gave the best results in terms of OS, control of the disease (PFS) and response to second line therapy after relapse (PFS2). Considering the remarkable progress done in the past decade the dream of a cure is a challenge for the future. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document